Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sugi Holdings Co ( (JP:7649) ) just unveiled an update.
Sugi Holdings reported that in March 2026 existing-store sales at Sugi Pharmacy rose 5.7% year on year, driven by a 3.2% increase in the drugstore segment and a robust 12.0% gain in the prescription business. On an all-store basis, sales climbed 8.5%, with drugstores up 6.7% and prescription operations up 13.1%, reflecting solid demand across its core healthcare and retail offerings.
The group opened 12 new stores and closed 3 during the month, bringing its total network to 2,330 locations at the end of March, underscoring continued expansion despite selective consolidation. The strong growth in prescription sales in particular signals ongoing reinforcement of Sugi’s position in Japan’s pharmacy and drugstore market, with scale gains likely to support operational efficiencies and customer reach.
The most recent analyst rating on (JP:7649) stock is a Buy with a Yen4100.00 price target. To see the full list of analyst forecasts on Sugi Holdings Co stock, see the JP:7649 Stock Forecast page.
More about Sugi Holdings Co
Sugi Holdings operates the Sugi Pharmacy chain in Japan, combining a drugstore business focused on daily necessities and health products with a prescription dispensing business. The group targets regional communities with integrated retail and pharmacy services, and continues to expand its nationwide footprint through new store openings under the Sugi Pharmacy brand.
Average Trading Volume: 727,338
Technical Sentiment Signal: Buy
Current Market Cap: Yen641.9B
See more insights into 7649 stock on TipRanks’ Stock Analysis page.

